Use of Fecal Microbial Transplantation for Immune Checkpoint Inhibitor Colitis

Immune checkpoint inhibitors (ICIs) can result in immune-related adverse events which require rapid identification and treatment. Gastrointestinal immune-related adverse events are among the most frequent and severe of these events. ICI colitis can be refractory to current therapies such as corticos...

Full description

Saved in:
Bibliographic Details
Published in:ACG case reports journal 2020-04, Vol.7 (4), p.e00360-e00360
Main Authors: Fasanello, Micaela K., Robillard, Kevin T., Boland, Patrick M., Bain, Andrew J., Kanehira, Kazunori
Format: Article
Language:English
Subjects:
Case Report
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Immune checkpoint inhibitors (ICIs) can result in immune-related adverse events which require rapid identification and treatment. Gastrointestinal immune-related adverse events are among the most frequent and severe of these events. ICI colitis can be refractory to current therapies such as corticosteroids and biologic therapy. Fecal microbiota transplantation (FMT) is currently used in cases of recurrent Clostridioides difficile colitis. Many investigations are underway to test the utility of FMT for additional indications, including inflammatory bowel disease (IBD). We present a 71-year-old man with ICI colitis that was nonresponsive to currently defined management options and treated with benefit from FMT.
ISSN:2326-3253
2326-3253
DOI:10.14309/crj.0000000000000360